Becton, Dickinson and Co’s $12bn acquisition of CareFusion ‘now complete’

On Tuesday (March 17th), it was announced that Becton, Dickinson and Co's (BD's) acquisition of CareFusion – worth $12 billion (8.17 billion pounds) – is now complete.

Last week, the European Union approved the buyout, which CareFusion's shareholders have already signed off, meaning the deal was officially advocated.

During its announcement, BD confirmed that it would be maintaining a significant presence in San Diego and advised that it has not forecast any major changes to the local payroll.

The deal with CareFusion marks the second-biggest purchase the life science company has made, with the first being the $13.6 billion buyout of Thermo Fisher Scientific's Carlsbad's Life Technologies, which was completed back in February 2014.

CareFusion is now wholly-owned by BD and the company's shares have officially ceased trading, and will soon be delisted on the New York Stock Exchange.

From the second half of the fiscal year, the firm will be included in a new BD Medical sector, which will be reported in BD's financial statements.